Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 465

1.

Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation.

Lou Z, O'Reilly S, Liang H, Maher VM, Sleight SD, McCormick JJ.

Cancer Res. 2005 Feb 1;65(3):1007-17.

2.

Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity.

Liang H, O'Reilly S, Liu Y, Abounader R, Laterra J, Maher VM, McCormick JJ.

Int J Oncol. 2004 May;24(5):1057-67.

PMID:
15067326
4.

Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.

Choe C, Chen N, Sawadogo M.

Exp Cell Res. 2005 Jan 1;302(1):1-10.

PMID:
15541720
5.

Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.

Detwiller KY, Fernando NT, Segal NH, Ryeom SW, D'Amore PA, Yoon SS.

Cancer Res. 2005 Jul 1;65(13):5881-9.

6.
7.

Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain.

Huang RP, Liu C, Fan Y, Mercola D, Adamson ED.

Cancer Res. 1995 Nov 1;55(21):5054-62.

8.

v-sis oncogene-induced transformation of human fibroblasts into cells capable of forming benign tumors.

Yang D, Kohler SK, Maher VM, McCormick JJ.

Carcinogenesis. 1994 Oct;15(10):2167-75.

PMID:
7955050
9.

Malignant transformation of human fibroblasts by a transfected N-ras oncogene.

Wilson DM, Yang DJ, Dillberger JE, Dietrich SE, Maher VM, McCormick JJ.

Cancer Res. 1990 Sep 1;50(17):5587-93.

10.
12.
13.

The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice.

Chand HS, Du X, Ma D, Inzunza HD, Kamei S, Foster D, Brodie S, Kisiel W.

Blood. 2004 Feb 1;103(3):1069-77.

14.

Overexpression of transcription factor Sp1 leads to gene expression perturbations and cell cycle inhibition.

Deniaud E, Baguet J, Chalard R, Blanquier B, Brinza L, Meunier J, Michallet MC, Laugraud A, Ah-Soon C, Wierinckx A, Castellazzi M, Lachuer J, Gautier C, Marvel J, Leverrier Y.

PLoS One. 2009 Sep 15;4(9):e7035. doi: 10.1371/journal.pone.0007035.

15.

E2F suppression and Sp1 overexpression are sufficient to induce the differentiation-specific marker, transglutaminase type 1, in a squamous cell carcinoma cell line.

Wong CF, Barnes LM, Dahler AL, Smith L, Popa C, Serewko-Auret MM, Saunders NA.

Oncogene. 2005 May 12;24(21):3525-34.

PMID:
15735752
16.

Overexpression of Sp1 transcription factor induces apoptosis.

Deniaud E, Baguet J, Mathieu AL, Pag├Ęs G, Marvel J, Leverrier Y.

Oncogene. 2006 Nov 9;25(53):7096-105.

PMID:
16715126
17.

Activation of the RNA-dependent protein kinase PKR promoter in the absence of interferon is dependent upon Sp proteins.

Das S, Ward SV, Tacke RS, Suske G, Samuel CE.

J Biol Chem. 2006 Feb 10;281(6):3244-53.

PMID:
16339759
19.

The HuT series of 'carcinogen-transformed' human fibroblast cell lines are derived from the human fibrosarcoma cell line 8387.

McCormick JJ, Yang DJ, Maher VM, Farber RA, Neuman W, Peterson WD Jr, Pollack MS.

Carcinogenesis. 1988 Nov;9(11):2073-9.

PMID:
2902939
20.
Items per page

Supplemental Content

Support Center